Navigation Links
Vanda Pharmaceuticals' VSF-173 Excessive Sleepiness Phase II Clinical Trial Suggests Wake-Promoting Properties
Date:10/30/2007

as recently initiated a Phase III study in primary insomnia. For more on Vanda Pharmaceuticals Inc., please visit http://www.vandapharma.com.

Note Regarding Forward-Looking Statements

This release contains forward-looking statements within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended, including statements regarding Vanda's plans for its product candidates. Words such as, but not limited to, "look forward to," "believe," "expect," "anticipate," "estimate," "intend," "plan," "targets," "likely," "will," "would," "should," and "could," and similar expressions or words identify forward-looking statements. Such forward-looking statements are based upon current expectations that involve risks, changes in circumstances, assumptions and uncertainties. Vanda is at an early stage of development and may not ever have any products that generate significant revenue. Important factors that could cause actual results to differ materially from those reflected in Vanda's forward-looking statements include, among others, a failure of Vanda's product candidates to be demonstrably safe and effective, a failure to obtain regulatory approval for the company's products or to comply with ongoing regulatory requirements, a lack of acceptance of Vanda's product candidates in the marketplace, a failure of the company to become or remain profitable, Vanda's inability to obtain the capital necessary to fund its research and development activities, a loss of any of the company's key scientists or management personnel, and other factors that are described in the "Risk Factors" section (Part II, Item 1A) of Vanda's report on Form 10-Q for the quarter ended June 30, 2007 (File No. 000-51863). No forward-looking statements can be guaranteed and actual results may differ materially from such statements. The information in this release is provided only as of the date of this release, and Vanda undertake
'/>"/>

SOURCE Vanda Pharmaceuticals Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. Supply of Radiopharmaceuticals Hampered by Attacks
2. FDA approves Watson Pharmaceuticals Oxytrol patch
3. Ranbaxy Pharmaceuticals Inc awarded the prestigious outstanding supplier award received from Wal-Mart
4. Antigenics Pharmaceuticals plans for Phase III trial of its Melanoma vaccine
5. United Kingdom Is Lagging In Novelty In The Field Of Pharmaceuticals
6. Top Pharmaceuticals Influence Doctors Prescriptions
7. More Study On Side Effects of ADHD Drug Needed: Shire Pharmaceuticals
8. Personalized Medicine and Innovative Pharmaceuticals
9. New lease of life for asthmatics by Accentia Biopharmaceuticals
10. Pravastatin Launched by Watson Pharmaceuticals
11. Tata Industries picks up stake in Indigene Pharmaceuticals
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/14/2014)... Wellesley, Mass. (PRWEB) July 14, 2014 ... its new report, SYNTHETIC BIOLOGY: GLOBAL MARKETS ... to grow to nearly $11.9 billion in 2018, ... of 34.4%. Enabled products account for the fastest ... and 36.7% CAGR. Synthetic biology-enabled products in the ...
(Date:7/14/2014)... SUNDAY, July 13, 2014 (HealthDay News) -- Along with ... people with Alzheimer,s disease and other types of dementia, ... their quality of life, the researchers said. "These ... variety of benefits for people with dementia and their ... Lerner, of Case Western Reserve University and University Hospitals ...
(Date:7/14/2014)... 14, 2014 (HealthDay News) -- Stress can slow a woman,s ... The study included 58 women, average age 53, who were ... given a meal than included 930 calories and 60 grams ... it took the women to burn off those calories and ... stressful events during the previous 24 hours burned 104 fewer ...
(Date:7/14/2014)... July 14, 2014 Skin ... its Grand Opening on Monday, July 14th, located ... The celebration will last all week through Saturday, ... patients. Everyone is welcomed to attend. The business ... provides physician-administered skincare, anti-aging, weight loss services, and ...
(Date:7/14/2014)... California (PRWEB) July 14, 2014 ... to reach USD 4,285.1 million by 2020 growing ... new study by Grand View Research, Inc. Steady ... biology for bioinformatics R&D programs designed for sequencing ... number of clinical studies in pharmacogenomics and pharmacokinetics ...
Breaking Medicine News(10 mins):Health News:Global Market for Synthetic Biology to Reach Nearly $11.9 Billion by 2018 — Enabled Products Account for the Fastest Growing Segment with 36.7% CAGR 2Health News:Global Market for Synthetic Biology to Reach Nearly $11.9 Billion by 2018 — Enabled Products Account for the Fastest Growing Segment with 36.7% CAGR 3Health News:Cataract Surgery a Plus for Someone With Dementia, Study Says 2Health News:Stress May Leave You Heading to the Cookie Jar 2Health News:The Cosmetic Medic Announces Grand Opening of New Skin M.D., a Physician-Administered Anti-aging, Skincare, and Weight Loss Practice 2Health News:The Cosmetic Medic Announces Grand Opening of New Skin M.D., a Physician-Administered Anti-aging, Skincare, and Weight Loss Practice 3Health News:Global Computational Biology Market by Application (Cellular & Biological Simulation), by Services (In-house, Contract) is Expected to Reach USD 4,285.1 Million by 2020 2Health News:Global Computational Biology Market by Application (Cellular & Biological Simulation), by Services (In-house, Contract) is Expected to Reach USD 4,285.1 Million by 2020 3Health News:Global Computational Biology Market by Application (Cellular & Biological Simulation), by Services (In-house, Contract) is Expected to Reach USD 4,285.1 Million by 2020 4Health News:Global Computational Biology Market by Application (Cellular & Biological Simulation), by Services (In-house, Contract) is Expected to Reach USD 4,285.1 Million by 2020 5Health News:Global Computational Biology Market by Application (Cellular & Biological Simulation), by Services (In-house, Contract) is Expected to Reach USD 4,285.1 Million by 2020 6
... ... Chicago, a chiropractor doctor, has developed new techniques to relieve back pain. People with herniated ... , ... 26, 2009 -- Dr. Paul Ruzila, Chiropractic Doctor of HealthSource of Chicago, announced today that ...
... Mary Hayashi Calls on California ... 3rd Annual "Neuropathy Action Awareness Day" , ... continues his push for national health care reform, more ... in Sacramento today to call on Congress to restore ...
... A U.S. District Court judge issued an injunction ... $2 cut in wages for the state,s 400,000 home care workers. ... California counties that were planning on passing the state cut through ... issued by federal judge Claudia Wilken, was in response to a ...
... Arrest Association said Thursday that pop singer Michael Jackson,s death ... cardiac arrest, which kills nearly 300,000 Americans each year and ... "Sudden cardiac arrest (SCA) is the result of an electrical ... attack. It can strike seemingly healthy individuals without warning, ...
... ... Researchers at the Baltimore Veterans Affairs (VA) Medical ... research using a novel ankle robot ("Anklebot"), invented by researchers at ... Veterans Affairs, with stroke patients at the Baltimore VA Medical ...
... In a 6-5 decision in Richmond Medical Center v. Herring ... on partial birth infanticide -- a law that mirrors the federal ... for Life (AUL) provided litigation support to the state ... law. In addition, AUL Senior Counsel Clarke Forsythe assisted the ...
Cached Medicine News:Health News:HealthSource of Chicago: New Techniques for Back Pain Relief in Chicago 2Health News:HealthSource of Chicago: New Techniques for Back Pain Relief in Chicago 3Health News:HealthSource of Chicago: New Techniques for Back Pain Relief in Chicago 4Health News:Neuropathy Patients, Doctors and Medical Professionals Rally in Sacramento to Demand Access to Lifesaving Medical Treatments 2Health News:Neuropathy Patients, Doctors and Medical Professionals Rally in Sacramento to Demand Access to Lifesaving Medical Treatments 3Health News:Veterans Affairs Researchers Study Benefits of Robot for Ankle Rehabilitation 2Health News:Veterans Affairs Researchers Study Benefits of Robot for Ankle Rehabilitation 3Health News:Veterans Affairs Researchers Study Benefits of Robot for Ankle Rehabilitation 4Health News:Americans United for Life Applauds Fourth Circuit Protecting Women and Children by Upholding Virginia Partial Birth Abortion Statute 2
(Date:7/14/2014)... , July 14, 2014 Lumin Medical ... the assets of PatientTrak, the leading provider of on-demand ... from Illinois to ... is Lumin which means light and our mission is ... patient satisfaction, increase efficiencies and reduce costs," said ...
(Date:7/14/2014)... N.J. , July 14, 2014  Invivotek ... LLC is pleased to announce that its animal ... Association for the Assessment and Accreditation of Laboratory ... treatment of animals in science worldwide through voluntary ... standards for animal care and use in 38 ...
(Date:7/14/2014)... 14, 2014  Remedy Informatics, the leading provider ... and life sciences research, announced that it has ... to build the first-ever national patient registry devoted ... pancreatitis. "The National Pancreas Foundation is ... thoughtful and committed organizations can effect upon society ...
Breaking Medicine Technology:Lumin Medical Purchases PatientTrak 2Lumin Medical Purchases PatientTrak 3Invivotek Awarded Full AAALAC Accreditation for Excellence in Laboratory Animal Care and Use 2Remedy Informatics Partners with National Pancreas Foundation to Build a National Patient Registry 2Remedy Informatics Partners with National Pancreas Foundation to Build a National Patient Registry 3
... 4, 2012  Elevation Pharmaceuticals, Inc. announced today the closing ... investor Novo Ventures , to fund development of Elevation,s ... disease (COPD). All previous investors participated in the round, including ... Capital and Mesa Verde Venture Partners . In ...
... 4, 2012 /PRNewswire-iReach/ -- DFH Pharma, ... focused exclusively in the HIV-1 therapeutic space, announced ... medicinal chemistry services to support DFH efforts to ... drugs. Maturation inhibitors are a novel class of ...
Cached Medicine Technology:Elevation Pharmaceuticals Completes $30 Million Series B Financing to Advance Aerosol COPD Therapy 2Elevation Pharmaceuticals Completes $30 Million Series B Financing to Advance Aerosol COPD Therapy 3DFH Pharma to Collaborate with CiVentiChem to Develop Second-Generation HIV Maturation Inhibitor Drugs 2DFH Pharma to Collaborate with CiVentiChem to Develop Second-Generation HIV Maturation Inhibitor Drugs 3
Round knurled handle. Overall length 130 mm....
Optimum Extra Strength cleaner is a sterile non-preserved cleaning solution for use with fluorosilicone acrylate and silicone acrylate rigid gas permeable (RGP) and all hard contact lenses of any pol...
Round knurled handle. Overall length 130 mm....
Hosford foreign body spud 4 3/4 inches, gouge blade 1 x 7 mm rounded tip, angled to left....
Medicine Products: